Task: Answer the multiple-choice question.
Question: Which drug exhibits a 28.733% human ether-à-go-go related gene (hERG) inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a: O=C(Nc1nc2ccc(Cl)cc2s1)C1CC1
b: Cc1ccc(S(=O)(=O)N2CCN(c3c([N+](=O)[O-])cc(C(F)(F)F)cc3[N+](=O)[O-])CC2)cc1
Answer: a. O=C(Nc1nc2ccc(Cl)cc2s1)C1CC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
O=C(Nc1nc2ccc(Cl)cc2s1)C1CC1
O=C(Nc1nc2ccc(Cl)cc2s1)C1CC1
N-(6-chloro-1,3-benzothiazol-2-yl)cyclopropanecarboxamide